Navigation Links
Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
Date:2/17/2010

alled RiVax™, which is designed to protect against the lethal effects of exposure to ricin toxin. RiVax™ has been shown to be well tolerated and immunogenic in a Phase 1 clinical trial in normal volunteers. RiVax™ is also the subject of a recent $9.4 million NIH grant received by the Company supporting development of new heat stable vaccines.

For further information regarding Soligenix, Inc., please visit the Company's website at www.soligenix.com.

This press release contains forward-looking statements that reflect Soligenix, Inc.'s current expectations about its future results, performance, prospects and opportunities. Statements that are not historical facts, such as "anticipates," "believes," "intends," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. Soligenix cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including orBec®, SGX201, RiVax™, and LPM™, particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will not exceed projected levels, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be abl
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... YORK , 22 de mayo de ... DPRX ), una compañía farmacéutica de ... comercialización de Locilex® (pexiganan cream 0.8%), y ... una presentación de póster destacando el diseño ... 3 de la Compañía que evalúan Locilex®, ...
(Date:5/22/2015)... 22, 2015 The Assistance Fund announces the ... provides financial assistance for copay to individuals diagnosed with ... the addition of the Melanoma Copay Assistance Program to ... , executive director. "With each additional program we are ... world where no one is denied access to medications ...
(Date:5/22/2015)... May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), ... repair and regeneration, today announced that J.J. Finkelstein ... present a corporate overview at two upcoming investor conferences. ... SeeThruEquity 4 th Annual Microcap Conference on Thursday ... at 11:00 am EDT.  A webcast will ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6The Assistance Fund Adds Melanoma Assistance Program 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... England, March 8, 2012 Circassia Ltd, ... that its ragweed allergy therapy has achieved positive results ... study, patients with more severe symptoms achieved a significantly ... than those on placebo (p≤0.05).  The results were presented ...
... 8, 2012 Sosei Group Corporation ("Sosei"; ... that its wholly owned Japanese subsidiary, Sosei Co., Ltd., ... for the treatment of oropharyngeal candidiasis. SO-1105 was originally ... received its first marketing authorization for SO-1105 in France ...
Cached Medicine Technology:Circassia's Ragweed Allergy Therapy Achieves Positive Phase II Clinical Results 2Circassia's Ragweed Allergy Therapy Achieves Positive Phase II Clinical Results 3Sosei Announces Initiation of Phase I Study for SO-1105 2
(Date:5/23/2015)... On May 16, the team at Farrell’s eXtreme Bodyshaping ... obstacle run that raised funds for multiple sclerosis. , ... reason we participated was to support people living with MS ... Bodyshaping. “One-hundred percent of the funds raised go to benefit ... only attended by eXtreme Bodyshaping staff, but members of the ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Javon ... at the Sports Medicine and Rehabilitation Center, 557 N. ... program, Mondays, June 1-July 20, 5:30-6:30 pm. , The ... coach, and Laurie Finke, RN, BSN, who will offer ... education on nutrition, running mechanics and show selection and ...
(Date:5/22/2015)... Calif. (PRWEB) May 22, 2015 ... technology, communication and capacity are intersecting to create ... across society, the opening speaker at WesternU's 34th ... California Lieut. Gov. Gavin Newsom, a former San ... the keynote speaker at the graduation ceremony for ...
(Date:5/22/2015)... Lehi, Utah (PRWEB) May 22, 2015 Mountain ... will host a ribbon cutting ceremony on Friday, May 29, ... 1 p.m. to 6 p.m. The new medical center, set ... 3000 North Triumph Boulevard, Lehi, UT 84043. , “The ... for our team and the Utah County community,” said Kent ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Following yesterday’s ... sale agreement with US-based health brand Nature’s Way, Marc ... brand. Retention of Ascenta Skin is an integral part ... excited about this opportunity to further develop Ascenta Skin ... , Ascenta Skin is a breakthrough, anti-aging skincare supplement ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2
... July 21 The Neutraceutical Company, LLC (TNC -- www.tncllc.com ... exclusive rights to direct market a remarkable new extract of an ... ways for centuries. This new, 100% natural product is the latest ... helping people cope with everyday health concerns. , ...
... , , BALTIMORE, July 21 ... to people that want to take control of their health, and ... to employers announced that they have reached an agreement to bring ... their employees - "stay healthy." , , ...
... , LONDON, July 21 Europe,s aging population ... diagnoses of respiratory diseases. While there has been a shift towards ... profit margins in this highly price sensitive market, while providing technologically ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , , ...
... , Project SHALEM: Partnering with the Faith-Based ... , BALTIMORE, July 21 Today, the ... at the University of Maryland School of Medicine, in partnership with ... Project SHALEM during City Uprising Baltimore ...
... , , , , ... DGX ), the world,s leading provider of diagnostic testing, ... 30, 2009, income from continuing operations rose to $188 million, or ... share, for the second quarter of 2008. These results include a ...
... , Project SHALEM: Partnering with ... , , BALTIMORE, July 21 ... Virology (IHV) at the University of Maryland School of Medicine, in ... organizations kicked-off Project SHALEM during City Uprising ...
Cached Medicine News:Health News:The Neutraceutical Company Announces Powerful New 'Feel-Good' Product 2Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 2Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 3Health News:Frost & Sullivan Examines the Key Challenges in the European Non-Invasive Ventilation Market 2Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 2Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 3Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 4Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 2Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 3Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 4Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 5Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 6Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 7Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 8Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 9Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 10Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 11Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 12Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 13Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 14Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 2Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 3Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 4
All Bovie LLETZ Loop and Square electrodes feature tungsten wire for superior shape and integrity throughout the excision procedure. They use a standard 3/32" (2.3 mm) shaft....
Autoclavable reusable pencil for Aaron 800 & 1200 - comes with generator or 1/box....
Disposable 1 1/4" Tungsten Micro Needle, Ins., Straight...
Split adult return electrode grounding pad with 2.8 m cable, 50/box....
Medicine Products: